Skip to content
UniqueBaseEN
For AI ↗
Companies

Biostate AI

Visit website ↗
Snapshot

As of Oct 15, 2026, UniqueBase lists 2 funding records for Biostate AI; the latest is $12M (Series A) on May 21, 2025.

Funding records
2
Latest round
$12M · Series A
Total raised (reported)
—
Rows with a source link
0 of 2

Overview

Predicting disease progression and drug responses through RNA sequencing and generative AI modeling

Funding · 2

Funding

Amounts as reported; USD estimates shown only when they match

Listed 2 funding records. Latest funding: $12M (Series A), May 21, 2025.

Annual trendUnit: USD
20242025$12MJul 9, 2024: $4M · SeedMay 21, 2025: $12M · Series A
DateAmountInvestorsSources
May 21, 2025$12M · Series AAccel, Catapult Ventures, Gaingels, Info Edge, Mana Ventures, Matter Venture Partners No source link
Jul 9, 2024$4M · SeedCaltech, Catapult Ventures, Matter Venture Partners, 元璟资本 No source link

Select ▸ on a row to see its source brief and links.

Valuation · 2

Valuation

Amounts as reported; USD estimates shown only when they match

Listed 2 valuation records.

Annual trendUnit: USD

No chartable valuation estimates yet.

2 listed records lack a clear date or positive USD estimate for the chart.

DateAmountInvestorsSources
May 21, 2025— · Series AAccel, Catapult Ventures, Gaingels, Info Edge, Mana Ventures, Matter Venture Partners No source link
Jul 9, 2024— · SeedCaltech, Catapult Ventures, Matter Venture Partners, 元璟资本 No source link

Select ▸ on a row to see its source brief and links.

Revenue

Revenue

Amounts as reported; USD estimates shown only when they match

No revenue records are listed yet.

No revenue rows to list.

Team, products & investors

Explore

Sources · 0

Sources & provenance

English text is maintained separately from the original record. Consult the original source before citing a fact.

No source links are available for this profile.

Original source text

Names may use phonetic renderings when no English name is supplied. The original wording is retained below.

通过 RNA 测序与生成式 AI 建模预测疾病进展及药物反应